A PHASE II STUDY OF THP (PIRARUBICIN)-COP THERAPY IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED PTCL: THP-3 STUDY OF JAPAN HEMATOPOIETIC MALIGNANCY CLINICAL STUDY GROUP

Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601

Oncology ◽

10.1159/000331681 ◽

2011 ◽

Vol 81 (2) ◽

pp. 84-90 ◽

Cited By ~ 6

Author(s):

Kenji Akie ◽

Satoshi Oizumi ◽

Shigeaki Ogura ◽

Naofumi Shinagawa ◽

Eiki Kikuchi ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Study Group ◽

Small Cell Lung ◽

Clinical Study Group ◽

Group Trial

Download Full-text

Multicenter Phase II Trial of Weekly Paclitaxel for Advanced or Metastatic Breast Cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyg075 ◽

2003 ◽

Vol 33 (8) ◽

pp. 371-376 ◽

Cited By ~ 18

Author(s):

K. Sato

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Study ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Weekly Paclitaxel ◽

Study Group ◽

Multicenter Phase ◽

Clinical Study Group

Download Full-text

Phase II Study of Amrubicin (AMR) for Patients with Non-Small Cell Lung Cancer (NSCLC) as Third-Line or Fourth-Line Chemotherapy: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901

Annals of Oncology ◽

10.1016/s0923-7534(20)32307-3 ◽

2012 ◽

Vol 23 ◽

pp. xi113

Author(s):

K. Itoh ◽

T. Harada ◽

K. Takamura ◽

E. Kikuchi ◽

S. Ohizumi ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Phase Ii Study ◽

Small Cell ◽

Study Group ◽

Small Cell Lung ◽

Clinical Study Group ◽

Third Line ◽

Group Trial ◽

Line Chemotherapy

Download Full-text

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)

Breast Cancer Research and Treatment ◽

10.1007/s10549-007-9529-4 ◽

2007 ◽

Vol 107 (1) ◽

pp. 87-94 ◽

Cited By ~ 17

Author(s):

Hiroyuki Takei ◽

Kimito Suemasu ◽

Kenichi Inoue ◽

Tsuyoshi Saito ◽

Katsuhiko Okubo ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Trial ◽

Operable Breast Cancer ◽

Study Group ◽

Hormone Receptor Positive ◽

Multicenter Phase ◽

Clinical Study Group

Download Full-text

Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group

Leukemia ◽

10.1038/s41375-021-01386-z ◽

2021 ◽

Author(s):

Carla Damaschin ◽

Helen Goergen ◽

Stefanie Kreissl ◽

Annette Plütschow ◽

Frank Breywisch ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Phase Ii ◽

Phase Ii Study ◽

Brentuximab Vedotin ◽

Study Group ◽

Advanced Stage ◽

Newly Diagnosed ◽

Classical Hodgkin Lymphoma ◽

Randomized Phase Ii

Download Full-text

A Phase II Study of Amrubicin as a Third‐Line or Fourth‐Line Chemotherapy for Patients With Non‐Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901

The Oncologist ◽

10.1634/theoncologist.2012-0308 ◽

2013 ◽

Vol 18 (4) ◽

pp. 439-445 ◽

Cited By ~ 14

Author(s):

Toshiyuki Harada ◽

Satoshi Oizumi ◽

Kenichiro Ito ◽

Kei Takamura ◽

Eiki Kikuchi ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Phase Ii Study ◽

Small Cell ◽

Study Group ◽

Small Cell Lung ◽

Clinical Study Group ◽

Third Line ◽

Group Trial ◽

Line Chemotherapy

Download Full-text

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone-sensitive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80388-5 ◽

2006 ◽

Vol 4 (2) ◽

pp. 155-156 ◽

Cited By ~ 1

Author(s):

H. Takei ◽

Suemasu ◽

K. Inoue ◽

T. Saito ◽

K. Okubo ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Phase Ii ◽

Phase Ii Trial ◽

Operable Breast Cancer ◽

Study Group ◽

Multicenter Phase ◽

Clinical Study Group ◽

Hormone Sensitive

Download Full-text

Docetaxel in Combination with Either Cisplatin or Gemcitabine in Unresectable Non-small Cell Lung Carcinoma: A Randomized Phase II Study by the Japan Lung Cancer Cooperative Clinical Study Group

Journal of Thoracic Oncology ◽

10.1097/01243894-200606000-00012 ◽

2006 ◽

Vol 1 (5) ◽

pp. 447-453 ◽

Cited By ~ 9

Author(s):

Nobuyuki Katakami ◽

Yuichi Takiguchi ◽

Kozo Yoshimori ◽

Hiroshi Isobe ◽

Akihiro Bessho ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Phase Ii Study ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Study Group ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Randomized Phase Ii ◽

Clinical Study Group

Download Full-text

Docetaxel in Combination with Either Cisplatin or Gemcitabine in Unresectable Non-small Cell Lung Carcinoma: A Randomized Phase II Study by the Japan Lung Cancer Cooperative Clinical Study Group

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(15)31610-5 ◽

2006 ◽

Vol 1 (5) ◽

pp. 447-453 ◽

Cited By ~ 5

Author(s):

Nobuyuki Katakami ◽

Yuichi Takiguchi ◽

Kozo Yoshimori ◽

Hiroshi Isobe ◽

Akihiro Bessho ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Phase Ii Study ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Study Group ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Randomized Phase Ii ◽

Clinical Study Group

Download Full-text

Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)

International Journal of Clinical Oncology ◽

10.1007/s10147-019-01436-8 ◽

2019 ◽

Vol 24 (8) ◽

pp. 966-975 ◽

Cited By ~ 1

Author(s):

Kazutaka Sunami ◽

Morio Matsumoto ◽

Shin-ichi Fuchida ◽

Eijiro Omoto ◽

Hiroyuki Takamatsu ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Therapy ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase Ii ◽

Phase Ii Study ◽

Study Group ◽

Newly Diagnosed

Download Full-text